Search our extensive Laboratory Test Directory to find test codes, ordering recommendations, specimen stability information, Test Fact Sheets, and more.
Recommendations when to order or not order the test. May include related or preferred tests.
Use to detect and quantify HIV-1. Use to determine HIV-1 drug resistance by DNA sequencing.
New York DOH Approval Status
Indicates whether a test has been approved by the New York State Department of Health.
This test is New York state approved.
Specimen Required
Patient PreparationInstructions patient must follow before/during specimen collection.
CollectSpecimen type to collect. May include collection media, tubes, kits, etc.
Lavender (EDTA), pink (K2EDTA), or plasma preparation tube (PPT).
Specimen PreparationInstructions for specimen prep before/after collection and prior to transport.
Separate from cells within 24 hours of collection. Transfer 4 mL plasma to an ARUP standard transport tube (ARUP supply #15824). Available online through eSupply using ARUP Connect™ or contact ARUP Client Services at 800-522-2787. (Minimum volume: 2.5 mL)
Storage/Transport TemperaturePreferred temperatures for storage prior to and during shipping to ARUP. See Stability for additional info.
Frozen
Unacceptable ConditionsCommon conditions under which a specimen will be rejected.
Serum. Heparinized specimens.
RemarksAdditional specimen collection, transport, or test submission information.
StabilityAcceptable times/temperatures for specimens. Times include storage and transport time to ARUP.
After separation from cells: Ambient: 24 hours (Critical: Ship FROZEN); Refrigerated: 72 hours; Frozen: 3 months
Expected turnaround time for a result, beginning when ARUP has received the specimen.
2-14 days
Reference Interval
Normal range/expected value(s) for a specific disease state. May also include abnormal ranges.
Not Detected
Test Number
Components
Reference Interval
HIV-1 Qnt by NAAT Interp
Not Detected
Interpretive Data
May include disease information, patient result explanation, recommendations, or details of testing.
Refer to report
Compliance Category
FDA
Note
Additional information related to the test.
If Human Immunodeficiency Virus 1 by Quantitative NAAT result is greater than or equal to 2.70 log copies/mL, then HIV- Drug Resistance by Next Generation Sequencing will be added. Additional charges apply.
The American Medical Association Current Procedural Terminology (CPT) codes published in ARUP's Laboratory Test Directory are provided for informational purposes only. The codes reflect our interpretation of CPT coding requirements based upon AMA guidelines published annually. CPT codes are provided only as guidance to assist clients with billing. ARUP strongly recommends that clients confirm CPT codes with their Medicare administrative contractor, as requirements may differ. CPT coding is the sole responsibility of the billing party. ARUP Laboratories assumes no responsibility for billing errors due to reliance on the CPT codes published.
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
Other names that describe the test. Synonyms.
HIV genotyping for drug sensitivity testing
HIV-1 reflex to genotyping
HIV-1 Treatment decision
HIV-1 viral load
Nucleic Acid Amplification Test (NAAT)
Viral load monitoring
Human Immunodeficiency Virus 1 (HIV-1) by Quantitative NAAT with Reflex to HIV-1 Drug Resistance by Next Generation Sequencing